Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now? [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
The company's Clinical Diagnostics arm is seeing increased demand for quality control, blood typing and diabetes products. Sound financial stability also appears encouraging. However, the impact of macroeconomic challenges on Bio-Rad's operations poses a concern. Persistent reduced demand in the Biopharma segment adds to the worry. In the past year, shares of this Zacks Rank #3 (Hold) company have dropped 22.1% compared with the 1.7% fall of the industry and a 25.6% rise of the S&P 500 composite. The renowned manufacturer and global supplier of clinical diagnostics and life science research products has a market capitalization of $8.24 billion. In the past five years, the company registered earnings growth of 15.6%, way ahead of the industry's 3.9% rise. Bio-Rad's earnings surpassed estimates in three of the trailing four quarters and missed in one, the average surprise being 4.2%. Let's delve deeper. Key Drivers Digital PCR Business Backs Growth: The pipeline of Bio-Rad's
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Global Urinalysis Market Size To Exceed USD 6.76 Billion By 2033 | CAGR of 5.41% [Yahoo! Finance]Yahoo! Finance
- Thermal Cyclers Market Worth 1.86 Billion 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]Yahoo! Finance
- Global Fecal Calprotectin Test Market Size To Exceed USD 366.15 Million By 2033 | CAGR of 11.24% [Yahoo! Finance]Yahoo! Finance
- Non-Viral Transfection Reagents Market worth USD 1,157.5 Million to 2031 - Exclusive Report by InsightAce Analytic [Yahoo! Finance]Yahoo! Finance
- $842.7 Million SDS Poly Acrylamide Gel Electrophoresis Market Forecast, 2030 - Featuring Profiles of 13 Companies Including Abcam, Bio-Rad Laboratories, GE Healthcare, and Thermo Fisher Scientific [Yahoo! Finance]Yahoo! Finance
BIO
Earnings
- 5/7/24 - Beat
BIO
Sec Filings
- 6/17/24 - Form 3
- 6/14/24 - Form 4
- 6/13/24 - Form 144
- BIO's page on the SEC website